421 related articles for article (PubMed ID: 26935510)
21. Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems.
Wang J; Tao W; Chen X; Farokhzad OC; Liu G
Theranostics; 2017; 7(16):3915-3919. PubMed ID: 29109787
[TBL] [Abstract][Full Text] [Related]
22. Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions.
Tomaszewski KA; Radomski MW; Santos-Martinez MJ
Nanomedicine (Lond); 2015 May; 10(9):1451-75. PubMed ID: 25996119
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications.
Kim H; Beack S; Han S; Shin M; Lee T; Park Y; Kim KS; Yetisen AK; Yun SH; Kwon W; Hahn SK
Adv Mater; 2018 Mar; 30(10):. PubMed ID: 29363198
[TBL] [Abstract][Full Text] [Related]
24. Nanomedicine in cardiovascular therapy: recent advancements.
Binsalamah ZM; Paul A; Prakash S; Shum-Tim D
Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):805-15. PubMed ID: 22894635
[TBL] [Abstract][Full Text] [Related]
25. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms.
Lanone S; Boczkowski J
Curr Mol Med; 2006 Sep; 6(6):651-63. PubMed ID: 17022735
[TBL] [Abstract][Full Text] [Related]
26. Potential applications and human biosafety of nanomaterials used in nanomedicine.
Su H; Wang Y; Gu Y; Bowman L; Zhao J; Ding M
J Appl Toxicol; 2018 Jan; 38(1):3-24. PubMed ID: 28589558
[TBL] [Abstract][Full Text] [Related]
27. Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST.
Dusinska M; Boland S; Saunders M; Juillerat-Jeanneret L; Tran L; Pojana G; Marcomini A; Volkovova K; Tulinska J; Knudsen LE; Gombau L; Whelan M; Collins AR; Marano F; Housiadas C; Bilanicova D; Halamoda Kenzaoui B; Correia Carreira S; Magdolenova Z; Fjellsbø LM; Huk A; Handy R; Walker L; Barancokova M; Bartonova A; Burello E; Castell J; Cowie H; Drlickova M; Guadagnini R; Harris G; Harju M; Heimstad ES; Hurbankova M; Kazimirova A; Kovacikova Z; Kuricova M; Liskova A; Milcamps A; Neubauerova E; Palosaari T; Papazafiri P; Pilou M; Poulsen MS; Ross B; Runden-Pran E; Sebekova K; Staruchova M; Vallotto D; Worth A
Nanotoxicology; 2015 May; 9 Suppl 1():118-32. PubMed ID: 25923349
[TBL] [Abstract][Full Text] [Related]
28. Potentials and emerging trends in nanopharmacology.
Jain K; Mehra NK; Jain NK
Curr Opin Pharmacol; 2014 Apr; 15():97-106. PubMed ID: 24598376
[TBL] [Abstract][Full Text] [Related]
29. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
[TBL] [Abstract][Full Text] [Related]
30. Accelerating the Translation of Nanomaterials in Biomedicine.
Mitragotri S; Anderson DG; Chen X; Chow EK; Ho D; Kabanov AV; Karp JM; Kataoka K; Mirkin CA; Petrosko SH; Shi J; Stevens MM; Sun S; Teoh S; Venkatraman SS; Xia Y; Wang S; Gu Z; Xu C
ACS Nano; 2015 Jul; 9(7):6644-54. PubMed ID: 26115196
[TBL] [Abstract][Full Text] [Related]
31. Principles and emerging applications of nanomagnetic materials in medicine.
Clavijo-Jordan V; Kodibagkar VD; Beeman SC; Hann BD; Bennett KM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):345-65. PubMed ID: 22488879
[TBL] [Abstract][Full Text] [Related]
32. Regenerative nanomedicine and the treatment of degenerative retinal diseases.
Zarbin MA; Montemagno C; Leary JF; Ritch R
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(1):113-37. PubMed ID: 22170869
[TBL] [Abstract][Full Text] [Related]
33. Toxicology of nanomaterials used in nanomedicine.
Zhao J; Castranova V
J Toxicol Environ Health B Crit Rev; 2011; 14(8):593-632. PubMed ID: 22008094
[TBL] [Abstract][Full Text] [Related]
34. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
Bertalan F; László B; Attila V
Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
[TBL] [Abstract][Full Text] [Related]
35. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.
Capretto L; Carugo D; Mazzitelli S; Nastruzzi C; Zhang X
Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1496-532. PubMed ID: 23933616
[TBL] [Abstract][Full Text] [Related]
36. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
[TBL] [Abstract][Full Text] [Related]
37. Luminescent lanthanide nanomaterials: an emerging tool for theranostic applications.
Ranjan S; Jayakumar MK; Zhang Y
Nanomedicine (Lond); 2015 May; 10(9):1477-91. PubMed ID: 25996120
[TBL] [Abstract][Full Text] [Related]
38. Nanotechnology in inflammation: cutting-edge advances in diagnostics, therapeutics and theranostics.
Liu Y; Lin Z; Wang Y; Chen L; Wang Y; Luo C
Theranostics; 2024; 14(6):2490-2525. PubMed ID: 38646646
[TBL] [Abstract][Full Text] [Related]
39. A Safe-by-Design Strategy towards Safer Nanomaterials in Nanomedicines.
Yan L; Zhao F; Wang J; Zu Y; Gu Z; Zhao Y
Adv Mater; 2019 Nov; 31(45):e1805391. PubMed ID: 30701603
[TBL] [Abstract][Full Text] [Related]
40. Nanoparticles for multiplex diagnostics and imaging.
Wang L; O'Donoghue MB; Tan W
Nanomedicine (Lond); 2006 Dec; 1(4):413-26. PubMed ID: 17716144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
